Belantamab in Combination with Dexamethasone in Patients with TripleClass Relapsed/Refractory Multiple Myeloma

被引：8

作者：

Atieh, Tahani ^{[1
]}

Atrash, Shebli ^{[2
,3
]}

Mohan, Meera ^{[4
]}

Shune, Leyla ^{[1
]}

Mahmoudjafari, Zahra ^{[5
]}

Quick, Julie ^{[6
]}

Riffel, Justin ^{[6
]}

McGuirk, Joseph P. ^{[5
]}

Mohyuddin, Ghulam Rehman ^{[7
]}

Abdallah, Al-Ola ^{[5
]}

Ahmed, Nausheen ^{[5
]}

Cui, Wei ^{[6
]}

Wishna, Anne ^{[6
]}

机构：

[1] Univ Kansas, Canc Ctr, Westwood, KS USA

[2] Levine Canc Inst Atrium Hlth, Plasma Cell Disorders Sect, Dept Hematol Oncol Blood Disorders, Charlotte, NC USA

[3] Univ Arkansas Med Sci, Charlotte, NC USA

[4] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA

[5] Univ Kansas, Div Hematol Malignancies Cellular Therapeut, Med Ctr, Kansas City, KS USA

[6] Univ Kansas, Med Ctr, Kansas City, KS USA

[7] Univ Utah, Salt Lake City, UT USA

来源：

关键词：

D O I：

10.1182/blood-2021-149791

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1642

引用

页数：4